世界の犬用関節炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Canine Arthritis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5644 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、犬用関節炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、オピオイド、幹細胞治療）、用途別市場規模（獣医病院＆診療所、小売薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・犬用関節炎治療薬の市場動向 ・企業の競争状況、市場シェア ・犬用関節炎治療薬の種類別市場規模と予測2016-2027（非ステロイド性抗炎症薬、オピオイド、幹細胞治療） ・犬用関節炎治療薬の用途別市場規模と予測2016-2027（獣医病院＆診療所、小売薬局、ドラッグストア） ・犬用関節炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・犬用関節炎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・犬用関節炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・犬用関節炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・犬用関節炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Elanco (Eli Lilly and Company)、Boehringer Ingelheim、Zoetis Inc、Vetoquinol S.A.、Bayer AG、Aratana Therapeutics Inc、Norbrook Laboratories Limited、VetStem Biopharma、Dechra Pharmaceuticals Plc） ・結論

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. 

Market Analysis and Insights: Global Canine Arthritis Therapeutics Market
The global Canine Arthritis Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Arthritis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Arthritis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Arthritis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Arthritis Therapeutics market.

Global Canine Arthritis Therapeutics Scope and Market Size
Canine Arthritis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Canine Arthritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy

Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.2.4 Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Canine Arthritis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Canine Arthritis Therapeutics Market Perspective (2016-2027)
2.2 Canine Arthritis Therapeutics Growth Trends by Regions
2.2.1 Canine Arthritis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Canine Arthritis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Canine Arthritis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Canine Arthritis Therapeutics Industry Dynamic
2.3.1 Canine Arthritis Therapeutics Market Trends
2.3.2 Canine Arthritis Therapeutics Market Drivers
2.3.3 Canine Arthritis Therapeutics Market Challenges
2.3.4 Canine Arthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Canine Arthritis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Canine Arthritis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Canine Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Arthritis Therapeutics Revenue
3.4 Global Canine Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Canine Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Therapeutics Revenue in 2020
3.5 Canine Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Canine Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Canine Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Canine Arthritis Therapeutics Breakdown Data by Type
4.1 Global Canine Arthritis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Canine Arthritis Therapeutics Breakdown Data by Application
5.1 Global Canine Arthritis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Canine Arthritis Therapeutics Market Size (2016-2027)
6.2 North America Canine Arthritis Therapeutics Market Size by Type
6.2.1 North America Canine Arthritis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Canine Arthritis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Canine Arthritis Therapeutics Market Size by Type (2016-2027)
6.3 North America Canine Arthritis Therapeutics Market Size by Application
6.3.1 North America Canine Arthritis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Canine Arthritis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Canine Arthritis Therapeutics Market Size by Application (2016-2027)
6.4 North America Canine Arthritis Therapeutics Market Size by Country
6.4.1 North America Canine Arthritis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Canine Arthritis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Canine Arthritis Therapeutics Market Size (2016-2027)
7.2 Europe Canine Arthritis Therapeutics Market Size by Type
7.2.1 Europe Canine Arthritis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Canine Arthritis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Canine Arthritis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Canine Arthritis Therapeutics Market Size by Application
7.3.1 Europe Canine Arthritis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Canine Arthritis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Canine Arthritis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Canine Arthritis Therapeutics Market Size by Country
7.4.1 Europe Canine Arthritis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Canine Arthritis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Canine Arthritis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Canine Arthritis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Canine Arthritis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Canine Arthritis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Canine Arthritis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Canine Arthritis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Canine Arthritis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Canine Arthritis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Canine Arthritis Therapeutics Market Size (2016-2027)
9.2 Latin America Canine Arthritis Therapeutics Market Size by Type
9.2.1 Latin America Canine Arthritis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Canine Arthritis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Canine Arthritis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Canine Arthritis Therapeutics Market Size by Application
9.3.1 Latin America Canine Arthritis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Canine Arthritis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Canine Arthritis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Canine Arthritis Therapeutics Market Size by Country
9.4.1 Latin America Canine Arthritis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Canine Arthritis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Canine Arthritis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Canine Arthritis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Canine Arthritis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Canine Arthritis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Canine Arthritis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Canine Arthritis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Canine Arthritis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Canine Arthritis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Elanco (Eli Lilly and Company)
11.1.1 Elanco (Eli Lilly and Company) Company Details
11.1.2 Elanco (Eli Lilly and Company) Business Overview
11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Therapeutics Introduction
11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.1.5 Elanco (Eli Lilly and Company) Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Canine Arthritis Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Details
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Canine Arthritis Therapeutics Introduction
11.3.4 Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.3.5 Zoetis Inc Recent Development
11.4 Vetoquinol S.A.
11.4.1 Vetoquinol S.A. Company Details
11.4.2 Vetoquinol S.A. Business Overview
11.4.3 Vetoquinol S.A. Canine Arthritis Therapeutics Introduction
11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.4.5 Vetoquinol S.A. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Canine Arthritis Therapeutics Introduction
11.5.4 Bayer AG Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Aratana Therapeutics Inc
11.6.1 Aratana Therapeutics Inc Company Details
11.6.2 Aratana Therapeutics Inc Business Overview
11.6.3 Aratana Therapeutics Inc Canine Arthritis Therapeutics Introduction
11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.6.5 Aratana Therapeutics Inc Recent Development
11.7 Norbrook Laboratories Limited
11.7.1 Norbrook Laboratories Limited Company Details
11.7.2 Norbrook Laboratories Limited Business Overview
11.7.3 Norbrook Laboratories Limited Canine Arthritis Therapeutics Introduction
11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.7.5 Norbrook Laboratories Limited Recent Development
11.8 VetStem Biopharma
11.8.1 VetStem Biopharma Company Details
11.8.2 VetStem Biopharma Business Overview
11.8.3 VetStem Biopharma Canine Arthritis Therapeutics Introduction
11.8.4 VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.8.5 VetStem Biopharma Recent Development
11.9 Dechra Pharmaceuticals Plc
11.9.1 Dechra Pharmaceuticals Plc Company Details
11.9.2 Dechra Pharmaceuticals Plc Business Overview
11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Introduction
11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2016-2021)
11.9.5 Dechra Pharmaceuticals Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Canine Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Key Players of Stem Cell Therapy
Table 5. Global Canine Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Canine Arthritis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Canine Arthritis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Canine Arthritis Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Canine Arthritis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Canine Arthritis Therapeutics Market Share by Regions (2022-2027)
Table 11. Canine Arthritis Therapeutics Market Trends
Table 12. Canine Arthritis Therapeutics Market Drivers
Table 13. Canine Arthritis Therapeutics Market Challenges
Table 14. Canine Arthritis Therapeutics Market Restraints
Table 15. Global Canine Arthritis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Canine Arthritis Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Arthritis Therapeutics as of 2020)
Table 18. Ranking of Global Top Canine Arthritis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Canine Arthritis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Canine Arthritis Therapeutics Product Solution and Service
Table 22. Date of Enter into Canine Arthritis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Canine Arthritis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Canine Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Canine Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Canine Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Canine Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Canine Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Canine Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Canine Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Canine Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Canine Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Canine Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Canine Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Canine Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Canine Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Canine Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Canine Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Canine Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Canine Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Canine Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Canine Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Canine Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Canine Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Canine Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Elanco (Eli Lilly and Company) Company Details
Table 63. Elanco (Eli Lilly and Company) Business Overview
Table 64. Elanco (Eli Lilly and Company) Canine Arthritis Therapeutics Product
Table 65. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Elanco (Eli Lilly and Company) Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Canine Arthritis Therapeutics Product
Table 70. Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. Zoetis Inc Company Details
Table 73. Zoetis Inc Business Overview
Table 74. Zoetis Inc Canine Arthritis Therapeutics Product
Table 75. Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Zoetis Inc Recent Development
Table 77. Vetoquinol S.A. Company Details
Table 78. Vetoquinol S.A. Business Overview
Table 79. Vetoquinol S.A. Canine Arthritis Therapeutics Product
Table 80. Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Vetoquinol S.A. Recent Development
Table 82. Bayer AG Company Details
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Canine Arthritis Therapeutics Product
Table 85. Bayer AG Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Bayer AG Recent Development
Table 87. Aratana Therapeutics Inc Company Details
Table 88. Aratana Therapeutics Inc Business Overview
Table 89. Aratana Therapeutics Inc Canine Arthritis Therapeutics Product
Table 90. Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Aratana Therapeutics Inc Recent Development
Table 92. Norbrook Laboratories Limited Company Details
Table 93. Norbrook Laboratories Limited Business Overview
Table 94. Norbrook Laboratories Limited Canine Arthritis Therapeutics Product
Table 95. Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Norbrook Laboratories Limited Recent Development
Table 97. VetStem Biopharma Company Details
Table 98. VetStem Biopharma Business Overview
Table 99. VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 100. VetStem Biopharma Recent Development
Table 101. Dechra Pharmaceuticals Plc Company Details
Table 102. Dechra Pharmaceuticals Plc Business Overview
Table 103. Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Product
Table 104. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Dechra Pharmaceuticals Plc Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 3. Opioids Features
Figure 4. Stem Cell Therapy Features
Figure 5. Global Canine Arthritis Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Veterinary Hospitals and Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Canine Arthritis Therapeutics Report Years Considered
Figure 10. Global Canine Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Canine Arthritis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Canine Arthritis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Canine Arthritis Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Canine Arthritis Therapeutics Market Share by Players in 2020
Figure 15. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Arthritis Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Canine Arthritis Therapeutics Revenue in 2020
Figure 17. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Canine Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Canine Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Canine Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Canine Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Canine Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Canine Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Canine Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Canine Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Canine Arthritis Therapeutics Market Share by Region (2016-2027)
Figure 39. China Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Canine Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Canine Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Canine Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Canine Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Canine Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Canine Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Canine Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 60. Zoetis Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 61. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 62. Bayer AG Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 63. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 64. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 65. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 66. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---